17 April 2025
Arexvy recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices GSK plc…
GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices GSK plc (LSE/NYSE: GSK) today announced that the US Centers for…
CQS New City High Yield Fund Limited(“NCYF” or the “Company”) Monthly Factsheet as at 31 March 2025 The Company’s Fact Sheet as at 31…
16 April 2025
2025 total net sales expected to be between €30 billion and €35 billion Today, ASML Holding NV (ASML) has published its 2025 first-quarter results. …
First quarter performance as anticipated, full year outlook unchanged Key Highlights Dolf van den Brink, Chairman of the Executive Board / CEO, commented: “In…
BUNZL Q1 TRADING STATEMENT Q1 profit below expectations; reduction to 2025 guidance; action plan in place This announcement contains inside information. Bunzl plc, the…
Greggs plc (the “Company”) Notice of Annual General Meeting and Annual Financial Report 2024 Following the announcement on 4 March 2025 of its full…
Solid performance while growth projects move ahead with pace Rio Tinto Chief Executive Jakob Stausholm said: “We continued to see strong operational improvement with…